|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.3100 - 0.3175|
|52 Week Range||0.1500 - 0.8950|
|Beta (3Y Monthly)||7.70|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VALENCIA, SPAIN, Oct. 02, 2018 -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and.
VALENCIA, SPAIN, Sept. 05, 2018-- via NEWMEDIAWIRE-- Zenosense, Inc., a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the ...
OTC:ZENO Zenosense, Inc. (OTC:ZENO) is a healthcare technology company located in Valencia, Spain. The company’s main focus is a novel hand-held point-of-care (POC) cardiac diagnostic device called MIDS ...
New York, New York--(Newsfile Corp. - June 28, 2018) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Diagnostics Play Critical Role in Medical Sector," featuring Zenosense (OTC Pink: ZENO). To hear the NetworkNewsAudio version, visit http://nnw.fm/kqyU7To read the original editorial, visit http://nnw.fm/8ZAlrDeveloped by the Company's MIDS Medical Limited joint venture (MML) based at the prestigious Sci-Tech Daresbury campus in the United Kingdom, MIDS Cardiac is a handheld POC technology for the detection of ...
Zenosense, Inc. , a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care handheld device for the early detection of certain cardiac ...